Open AccessTactics of the physician-controlled counter—detail and the imminent risk of not changing pharma’s detail relationship with physicians
Author(s) -
Scott A. Kale,
Robert L. Barkin
Publication year - 2007
Publication title -
journal of opioid management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 39
eISSN - 2375-0146
pISSN - 1551-7489
DOI - 10.5055/jom.2007.0009
Subject(s) - medicine , possession (linguistics) , family medicine , depression (economics) , chronic pain , clinical pharmacology , alternative medicine , medical emergency , psychiatry , pharmacology , philosophy , linguistics , pathology , economics , macroeconomics
The traditional relationship between physicians and drug companies is imperiled because the perceived clinical value of the sales detail is found to be increasingly barren of clinical relevancy by physicians. There is an urgent need to train physicians to more effectively mine and refine the data offered by pharma for the benefit of present and future patients. The ability of doctors to use medicines for chronic disease states such as chronic pain, diabetes, hyperlipedemias, depression would be vastly improved if doctors were in possession of clinically relevant data that pharma has, but does not share with clinicians. Doctors must take control of the detail to extract this vital clinical information.